Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTAEXE vonoprazan for sleep disturbance associated with reflux esophagitis
jRCT1080223483Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vonoprazan in erosive esophagitis (EE) and sleep disorder, sponsored by Takeda. Started Mar 2017; status: completed.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)sleep disorder
Beyond the preview
Go deeper on jRCT1080223483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223483.